KELSIE MONTGOMERY: Open Payments
NPI 1437672326 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 98 payments from 27 companies in 2025. Trend: 2023 $2,790 · 2024 $2,755 · 2025 $2,102
Food & beverage: $2,017Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $378 |
| PFIZER INC. | 9 | $201 |
| Janssen Biotech, Inc. | 4 | $191 |
| Novartis Pharmaceuticals Corporation | 7 | $176 |
| Alexion Pharmaceuticals, Inc. | 6 | $129 |
| ARGENX US, INC. | 5 | $123 |
| Merz Pharmaceuticals, LLC | 2 | $103 |
| Boston Scientific Corporation | 1 | $78 |
| UCB, Inc. | 3 | $77 |
| Biogen, Inc. | 4 | $71 |
Products named: QULIPTA, KESIMPTA, NURTEC ODT, ULTOMIRIS, UBRELVY, VYVGART HYTRULO, Xeomin, WaveWriter Alpha Prime 16.
Industry payments across UT — which companies pay providers there.
